Investigational New Drugs
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
- PublisherSPRINGER
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1983
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 72% |
| 4-6 | 25% |
| 7-9 | 3% |
| >9 | 0% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Investigational New Drugs been publishing? 
The Investigational New Drugs has been publishing since 1983 till date.
How frequently is the Investigational New Drugs published?
Investigational New Drugs is published Bi-monthly.
What is the H-index. SNIP score, Citescore and SJR of Investigational New Drugs?
Investigational New Drugs has a H-index score of 94, Citescore of 6.2, SNIP score of 0.85, & SJR of Q1
Who is the publisher of Investigational New Drugs?
The publisher of Investigational New Drugs is SPRINGER.
How can I view the journal metrics of Investigational New Drugs on editage?
For the Investigational New Drugs metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Investigational New Drugs?
The eISSN number is 1573-0646 and pISSN number is 0167-6997 for Investigational New Drugs.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Drug discovery, Cancer, Lung cancer, Maximum tolerated dose, Whole blood, Bioinformatics analysis, Hepatocellular carcinoma, Toxicity, Signal transduction, Breast cancer, Immunotherapy, Oral administration, Epidermal growth factor receptor, Nivolumab, Chemoradiotherapy, Overall survival, Erlotinib, Microscale thermophoresis, Mesothelioma, Progression-free survival.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.